MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    International, multicenter validation study of the Shame in Parkinson’s disease (SPARK) Scale

    C. Rodriguez-Blazquez, I. Debove, A. Ayala, V. Fleury, A. Zenger, M. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, MA. Qamar, H. Reichmann, S. Bostantjopoulou, M. Bereau, MJ. Forjaz, P. Martinez-Martin, P. Krack (Madrid, Spain)

    Objective: To evaluate the psychometric properties of the Shame in PARKinson’s disease (SPARK) Scale in Parkinson’s disease patients, using both classical test theory (CTT) and…
  • 2026 International Congress

    Healthcare Resource Utilization and Associated Costs in Adults with Isolated Dystonia in the United States

    M. Oldham, J. Kerner, S. Dasgupta, J. Imperato, J. Thornton (Cambridge, USA)

    Objective: To evaluate all-cause healthcare resource utilization (HCRU) and costs in adults with isolated dystonia in the United States. Background: Isolated dystonia is a rare,…
  • 2026 International Congress

    Functional Movement Disorders in Older Adults in Latin America: A Narrative Literature Review

    M. Bonilla-Arbeláez, M. Wongpaiboon, J. Urrea-Perez, A. Ramirez-Zamora, E. Urrea-Mendoza (Caldas, Colombia)

    Objective: To review the available literature on FMD in older adults (aged ≥ 65 years) in Latin America, focusing on epidemiology, clinical features, diagnostic challenges, treatment, and…
  • 2026 International Congress

    Clinician Guided Multimodal Kinematic AI System for Objective Assessment in Parkinson’s Disease

    V. Tyagi, P. Silburn, Y. Pathak, D. Diaconescu (plano, USA)

    Objective: To evaluate the feasibility of developing a novel Multimodal Kinematic Artificial Intelligence (MKAI) system, uniquely guided by expert physician evaluation notes, to generate objective,…
  • 2026 International Congress

    Identification of Alpha-synuclein Pathology in Dementia with Lewy Body Participants by Seed Amplification Assay

    C. Farris, S. Weber, Y. Ma, M. Starke, B. Mollenhauer, L. Concha (San Diego, USA)

    Objective: To assess frequency and type of misfolded α-synuclein aggregates (syn-seeds) in cerebrospinal fluid (CSF) from dementia with Lewy bodies (DLB) participants by means of…
  • 2026 International Congress

    Reducing Cost and Operative Time in DBS with a Consolidated Workflow: A Time-Driven Activity-Based Costing Analysis

    A. Goyal, B. Dong, A. Bansal, M. Marsans, S. Srivatsal, F. Farrokhi (Albany, USA)

    Objective: To show that a consolidated patient specific workflow significantly improved operative efficiency and reduced personnel costs for deep brain stimulation (DBS) implantation, without compromise…
  • 2026 International Congress

    Longitudinal motor network responses to pallidal DBS in cervical dystonia: an ongoing DBS-fMRI study

    E. Cito, S. Deutsch, S. Wang, D. Mikhael, J. Ostrem, M. San Luciano, I. Bledsoe, M. Morrison (San Francisco, USA)

    Objective: This longitudinal MRI study in cervical dystonia uses functional MRI (fMRI) to evaluate neural mechanisms underlying clinical response to deep brain stimulation (DBS), with…
  • 2026 International Congress

    Social Determinants of Health and MSA survival

    Y. Goh, V. Chelban, N. Vijiaratnam, C. Girges, R. Fumi, T. Foltynie, H. Morris, H. Houlden (London, United Kingdom)

    Objective: To investigate how social determinants of health affect survival in people with Multiple System Atrophy Background: The wider determinants of health (e.g. socioeconomic and…
  • 2026 International Congress

    The Lewy Body Dementia Domain Rating Scale (LBD-DRS): Patient and Care Partner Perspectives

    E. Matar, B. Boeve, D. Galasko, J. Kane, F. Rodriguez-Porcel, A. Schrag, S. Sikkes, J. Taylor (Sydney, Australia)

    Objective: To develop and validate the Lewy Body Dementia Domain Rating Scale (LBD-DRS), a disease-specific outcome measure designed to comprehensively capture the clinical features and…
  • 2026 International Congress

    MT200605 for Huntington’s Disease: Nonclinical finding and Phase I Clinical Result

    L. Yongzhen, W. Ying, W. Xiangling, W. Xiaobing, W. Linyuan, W. Ruiling, H. Zhian, W. Bing (XIAN, China)

    Objective: To summarize the efficacy of the oral MT200605 formulation in a Huntington’s disease (HD) mouse model and current clinical progress of MT200605. Background: MT200605…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley